Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics

The past century's description of oncolytic virotherapy as a cancer treatment involving specially-engineered viruses that exploit immune deficiencies to selectively lyse cancer cells is no longer adequate. Some of the most promising therapeutic candidates are now being engineered to produce im...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter S. Kim, Joseph J. Crivelli, Il-Kyu Choi, Chae-Ok Yun, Joanna R. Wares
Format: Article
Language:English
Published: AIMS Press 2015-03-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2015.12.841
Tags: Add Tag
No Tags, Be the first to tag this record!